Abstract
Aim: The benefit of chemotherapy as neoadjuvant or concurrent with radiotherapy in terms of overall survival has been demonstrated in locally advanced head and neck squamous cell cancer. We aimed to assess the efficacy and safety of concurrent capecitabine and cisplatin over concurrent cisplatin and 5-FU in locally advanced squamous cell oral cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have